Alkemists Pharmaceuticals (Costa Mesa, CA) is on its way to becoming a carbon-neutral analytical laboratory by offsetting 100% of its CO2 emissions, the company said on July 30.
Alkemists Pharmaceuticals (Costa Mesa, CA) is on its way to becoming a carbon-neutral analytical laboratory by offsetting 100% of its CO2 emissions, the company said on July 30.
“Today, it is difficult not to be aware of the imbalances we have inadvertently created for our planet,” said Alkemists Pharmaceuticals lab manager Elan Sudberg. “As a contributing factor in the various environmental issues, I feel that it is our responsibility to be accountable in some way.”
Sudberg said that by working with Green Mountain Energy Co. (Austin), Alkemists has been able to calculate a CO2 emissions footprint of 31 metric tons for the lab’s annual electricity, refrigerant, and natural gas usage, along with emissions caused by employee commuting and corporate air travel.
The company will offset all of its 2007 and 2008 electricity- and refrigerant-related CO2 emissions by purchasing renewable energy credits from wind sources. It also plans to offset 100% of the emissions created during those years by natural gas usage, employee commuting, and corporate air travel by purchasing forest sequestration offsets.
“Going carbon neutral is a great and incredibly simple way to move forward in a meaningful attempt to undo the harmful byproducts of operating an analytical laboratory,” said Sudberg. “In fact, we are going above and beyond our calculated emissions by working with the Arbor Day Foundation and their Rain Forest Rescue and Reforestation Program.”
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.